Clinical Benefit of Low Molecular Weight Heparin for ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Glycoprotein IIb/IIIa Inhibitor

The efficacy of low molecular weight heparin (LMWH) with low dose unfractionated heparin (UFH) during percutaneous coronary intervention (PCI) with or without glycoprotein (Gp) IIb/IIIa inhibitor compared to UFH with or without Gp IIb/IIIa inhibitor has not been elucidated. Between October 2005 and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Cho, Jung Sun, Her, Sung-Ho, Baek, Ju Yeal, Park, Mahn-Won, Kim, Hyoung Doo, Jeong, Myung Ho, Ahn, Young keun, Chae, Shung Chull, Hur, Seung Ho, Hong, Taek Jong, Kim, Young Jo, Seong, In Whan, Chae, Jei Keon, Rhew, Jay Young, Chae, In Ho, Cho, Myeong Chan, Bae, Jang Ho, Rha, Seung Woon, Kim, Chong Jim, Choi, Donghoon, Jang, Yang Soo, Yoon, Junghan, Chung, Wook Sung, Cho, Jeong Gwan, Seung, Ki Bae, Park, Seung Jung
Format: Artigo
Idioma:Inglês
Publicat: The Korean Academy of Medical Sciences 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966997/
https://ncbi.nlm.nih.gov/pubmed/21060749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2010.25.11.1601
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars